Skip to main content

2021 | OriginalPaper | Buchkapitel

Signaling Networks Involved in the Malignant Transformation of Breast Cancer

verfasst von : Mizuki Yamamoto, Jun-ichiro Inoue

Erschienen in: Methods of Mathematical Oncology

Verlag: Springer Singapore

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Breast cancer stem cells (CSCs) are involved the malignant transformation of breast cancer, including metastasis, because they are more stress-resistant and have higher tumorigenicity than the surrounding breast cancer cells (non-CSCs). We aimed to elucidate the various signaling networks involved in the transformation of mammary epithelial cells into tumor cells based on literature review. We found that constitutive activation of the NF-\({\upkappa}{\text{B}}\) pathway maintains CSCs in basal-like breast cancer, a subtype of triple-negative breast cancer, where NF-\({\upkappa}{\text{B}}\)-mediated induction of JAG1 in non-CSCs results in the stimulation of Notch signaling in CSCs. On the other hand, epithelial-mesenchymal transition (EMT) and its reverse reaction, mesenchymal-epithelial transition (MET), are thought to be involved in breast cancer cell metastasis, which makes elucidating their regulatory mechanisms essential. We identified HCC38, a basal-like breast cancer cell line, as a suitable model to investigate such mechanisms, because EMT and MET are in intratumoral equilibrium with each other in HCC38. In the HCC38 study, we found that multiple signaling pathways between epithelial and mesenchymal cells are involved in the regulation of the dynamic equilibrium between EMT and MET. Mathematical simulation of these intracellular and intercellular signaling networks involved in the malignant transformation of breast cancer could lead to the elucidation of the mechanisms of tumor malignant transformation and the development of therapeutic targets.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Vargo-Gogola, T., Rosen, J.M.: Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7(9), 659–672 (2007)CrossRef Vargo-Gogola, T., Rosen, J.M.: Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 7(9), 659–672 (2007)CrossRef
2.
Zurück zum Zitat Herschkowitz, J.I., Simin, K., Weigman, V.J., Mikaelian, I., Usary, J., Hu, Z., et al.: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8(5), R76 (2007)CrossRef Herschkowitz, J.I., Simin, K., Weigman, V.J., Mikaelian, I., Usary, J., Hu, Z., et al.: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8(5), R76 (2007)CrossRef
3.
Zurück zum Zitat Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J.S., Nobel, A., et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U S A. 100(14), 8418–8423 (2003)CrossRef Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J.S., Nobel, A., et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U S A. 100(14), 8418–8423 (2003)CrossRef
4.
Zurück zum Zitat Neve, R.M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F.L., Fevr, T., et al.: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6), 515–527 (2006)CrossRef Neve, R.M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F.L., Fevr, T., et al.: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10(6), 515–527 (2006)CrossRef
5.
Zurück zum Zitat Lim, E., Vaillant, F., Wu, D., Forrest, N.C., Pal, B., Hart, A.H., et al.: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 15(8), 907–913 (2009)CrossRef Lim, E., Vaillant, F., Wu, D., Forrest, N.C., Pal, B., Hart, A.H., et al.: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 15(8), 907–913 (2009)CrossRef
6.
Zurück zum Zitat Molyneux, G., Geyer, F.C., Magnay, F.A., McCarthy, A., Kendrick, H., Natrajan, R., et al.: BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7(3), 403–417 (2010)CrossRef Molyneux, G., Geyer, F.C., Magnay, F.A., McCarthy, A., Kendrick, H., Natrajan, R., et al.: BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7(3), 403–417 (2010)CrossRef
7.
Zurück zum Zitat Visvader, J.E.: Cells of origin in cancer. Nature 469(7330), 314–322 (2011)CrossRef Visvader, J.E.: Cells of origin in cancer. Nature 469(7330), 314–322 (2011)CrossRef
8.
Zurück zum Zitat Bonnet, D., Dick, J.E.: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3(7), 730–737 (1997)CrossRef Bonnet, D., Dick, J.E.: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3(7), 730–737 (1997)CrossRef
9.
Zurück zum Zitat Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F.: Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U S A. 100(7), 3983–3988 (2003)CrossRef Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F.: Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U S A. 100(7), 3983–3988 (2003)CrossRef
10.
Zurück zum Zitat Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., et al.: Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. U S A. 104(41), 16158–16163 (2007)CrossRef Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., et al.: Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. U S A. 104(41), 16158–16163 (2007)CrossRef
11.
Zurück zum Zitat Iliopoulos, D., Hirsch, H.A., Struhl, K.: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139(4), 693–706 (2009)CrossRef Iliopoulos, D., Hirsch, H.A., Struhl, K.: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139(4), 693–706 (2009)CrossRef
12.
Zurück zum Zitat Harrison, H., Farnie, G., Howell, S.J., Rock, R.E., Stylianou, S., Brennan, K.R., et al.: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 70(2), 709–718 (2010)CrossRef Harrison, H., Farnie, G., Howell, S.J., Rock, R.E., Stylianou, S., Brennan, K.R., et al.: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 70(2), 709–718 (2010)CrossRef
13.
Zurück zum Zitat Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704–715 (2008)CrossRef Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704–715 (2008)CrossRef
14.
Zurück zum Zitat Ginestier, C., Liu, S., Diebel, M.E., Korkaya, H., Luo, M., Brown, M., et al.: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 120(2), 485–497 (2010)CrossRef Ginestier, C., Liu, S., Diebel, M.E., Korkaya, H., Luo, M., Brown, M., et al.: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 120(2), 485–497 (2010)CrossRef
15.
Zurück zum Zitat Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J.B., Zhang, Y.: NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res. Treat. 111(3), 419–427 (2008)CrossRef Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J.B., Zhang, Y.: NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res. Treat. 111(3), 419–427 (2008)CrossRef
16.
Zurück zum Zitat Liu, M., Sakamaki, T., Casimiro, M.C., Willmarth, N.E., Quong, A.A., Ju, X., et al.: The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 70(24), 10464–10473 (2010)CrossRef Liu, M., Sakamaki, T., Casimiro, M.C., Willmarth, N.E., Quong, A.A., Ju, X., et al.: The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 70(24), 10464–10473 (2010)CrossRef
17.
Zurück zum Zitat Murohashi, M., Hinohara, K., Kuroda, M., Isagawa, T., Tsuji, S., Kobayashi, S., et al.: Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. Br. J. Cancer 102(1), 206–212 (2010)CrossRef Murohashi, M., Hinohara, K., Kuroda, M., Isagawa, T., Tsuji, S., Kobayashi, S., et al.: Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. Br. J. Cancer 102(1), 206–212 (2010)CrossRef
18.
Zurück zum Zitat Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., et al.: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6), 1109–1123 (2007)CrossRef Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., et al.: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6), 1109–1123 (2007)CrossRef
19.
Zurück zum Zitat Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., et al.: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239), 780–783 (2009)CrossRef Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., et al.: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239), 780–783 (2009)CrossRef
20.
Zurück zum Zitat Yamaguchi, N., Ito, T., Azuma, S., Ito, E., Honma, R., Yanagisawa, Y., et al.: Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100(9), 1668–1674 (2009)CrossRef Yamaguchi, N., Ito, T., Azuma, S., Ito, E., Honma, R., Yanagisawa, Y., et al.: Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci. 100(9), 1668–1674 (2009)CrossRef
21.
Zurück zum Zitat Yamamoto, M., Ito, T., Shimizu, T., Ishida, T., Semba, K., Watanabe, S., et al.: Epigenetic alteration of the NF-\({\upkappa}{\text{B}}\)-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 101(11), 2391–2397 (2010) Yamamoto, M., Ito, T., Shimizu, T., Ishida, T., Semba, K., Watanabe, S., et al.: Epigenetic alteration of the NF-\({\upkappa}{\text{B}}\)-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 101(11), 2391–2397 (2010)
22.
Zurück zum Zitat Yamamoto, M., Taguchi, Y., Ito-Kureha, T., Semba, K., Yamaguchi, N., Inoue, J.: NF-\({\upkappa}{\text{B}}\) non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat. Commun. 4, 2299 (2013) Yamamoto, M., Taguchi, Y., Ito-Kureha, T., Semba, K., Yamaguchi, N., Inoue, J.: NF-\({\upkappa}{\text{B}}\) non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat. Commun. 4, 2299 (2013)
23.
Zurück zum Zitat Yamamoto, M., Abe, C., Wakinaga, S., Sakane, K., Yumiketa, Y., Taguchi, Y., et al.: TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion. Commun. Biol. 2, 292 (2019)CrossRef Yamamoto, M., Abe, C., Wakinaga, S., Sakane, K., Yumiketa, Y., Taguchi, Y., et al.: TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion. Commun. Biol. 2, 292 (2019)CrossRef
25.
Zurück zum Zitat Yu, M., Bardia, A., Wittner, B.S., Stott, S.L., Smas, M.E., Ting, D.T., et al.: Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119), 580–584 (2013)CrossRef Yu, M., Bardia, A., Wittner, B.S., Stott, S.L., Smas, M.E., Ting, D.T., et al.: Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119), 580–584 (2013)CrossRef
26.
Zurück zum Zitat Scheel, C., Eaton, E.N., Li, S.H., Chaffer, C.L., Reinhardt, F., Kah, K.J., et al.: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145(6), 926–940 (2011)CrossRef Scheel, C., Eaton, E.N., Li, S.H., Chaffer, C.L., Reinhardt, F., Kah, K.J., et al.: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145(6), 926–940 (2011)CrossRef
27.
Zurück zum Zitat Yamamoto, M., Sakane, K., Tominaga, K., Gotoh, N., Niwa, T., Kikuchi, Y., et al.: Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer. Cancer Sci. 108(6), 1210–1222 (2017)CrossRef Yamamoto, M., Sakane, K., Tominaga, K., Gotoh, N., Niwa, T., Kikuchi, Y., et al.: Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer. Cancer Sci. 108(6), 1210–1222 (2017)CrossRef
28.
Zurück zum Zitat Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., et al.: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10(2), 202–210 (2008)CrossRef Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., et al.: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 10(2), 202–210 (2008)CrossRef
29.
Zurück zum Zitat Wellner, U., Schubert, J., Burk, U.C., Schmalhofer, O., Zhu, F., Sonntag, A., et al.: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11(12), 1487–1495 (2009)CrossRef Wellner, U., Schubert, J., Burk, U.C., Schmalhofer, O., Zhu, F., Sonntag, A., et al.: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11(12), 1487–1495 (2009)CrossRef
Metadaten
Titel
Signaling Networks Involved in the Malignant Transformation of Breast Cancer
verfasst von
Mizuki Yamamoto
Jun-ichiro Inoue
Copyright-Jahr
2021
Verlag
Springer Singapore
DOI
https://doi.org/10.1007/978-981-16-4866-3_17